소프트 미스트 흡입기 시장 - 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Soft Mist Inhalers Market - Scope of Report

TMR's report on the global soft mist inhalers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global soft mist inhalers market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global soft mist inhalers market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the soft mist inhalers market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global soft mist inhalers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global soft mist inhalers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global soft mist inhalers market.

The report delves into the competitive landscape of the global soft mist inhalers market. Key players operating in the global soft mist inhalers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global soft mist inhalers market profiled in this report.

Key Questions Answered in Global soft mist inhalers Market Report:

• What is the sales/revenue generated by soft mist inhalers across all regions during the forecast period?
• What are the opportunities in the global soft mist inhalers market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Soft Mist Inhalers Market - Research Objectives and Research Approach

The comprehensive report on the global soft mist inhalers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global soft mist inhalers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global soft mist inhalers market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Soft Mist Inhalers Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Type Definition
  • 4.1.2. Industry Evolution / Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Soft Mist Inhalers Market Analysis and Forecasts, 2017-2031

5. Key Insights

• 5.1. Pipeline Analysis
• 5.2. Regulatory Scenario by Region/Globally
• 5.3. Disease Prevalence & Incidence Rate Globally with Key Countries
• 5.4. COVID-19 Impact Analysis

6. Global Soft Mist Inhalers Market Analysis and Forecasts, By Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Type, 2017-2031
  • 6.3.1. Disposable
  • 6.3.2. Reusable
• 6.4. Market Attractiveness By Type

7. Global Soft Mist Inhalers Market Analysis and Forecasts, By Age Group

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Age Group, 2017-2031
  • 7.3.1. Adults
  • 7.3.2. Pediatrics
• 7.4. Market Attractiveness By Age Group

8. Global Soft Mist Inhalers Market Analysis and Forecasts, By Application

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Application, 2017-2031
  • 8.3.1. Asthma
  • 8.3.2. COPD
  • 8.3.3. Others (Cystic Fibrosis, etc.)
• 8.4. Market Attractiveness By Application

9. Global Soft Mist Inhalers Market Analysis and Forecasts, By End-user

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By End-user, 2017-2031
  • 9.3.1. Hospitals
  • 9.3.2. Clinics
  • 9.3.3. Others (Home Care, etc.)
• 9.4. Market Attractiveness By End-user

10. Global Soft Mist Inhalers Market Analysis and Forecasts, By Region

• 10.1. Key Findings
• 10.2. Market Value Forecast By Region
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness By Country/Region

11. North America Soft Mist Inhalers Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Type, 2017-2031
  • 11.2.1. Disposable
  • 11.2.2. Reusable
• 11.3. Market Value Forecast By Age Group, 2017-2031
  • 11.3.1. Adults
  • 11.3.2. Pediatrics
• 11.4. Market Value Forecast By Application, 2017-2031
  • 11.4.1. Asthma
  • 11.4.2. COPD
  • 11.4.3. Others (Cystic Fibrosis, etc.)
• 11.5. Market Value Forecast By End-user, 2017-2031
  • 11.5.1. Hospitals
  • 11.5.2. Clinics
  • 11.5.3. Others (Home Care, etc.)
• 11.6. Market Value Forecast By Country, 2017-2031
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Type
  • 11.7.2. By Age Group
  • 11.7.3. By Application
  • 11.7.4. By End-user
  • 11.7.5. By Country

12. Europe Soft Mist Inhalers Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Type, 2017-2031
  • 12.2.1. Disposable
  • 12.2.2. Reusable
• 12.3. Market Value Forecast By Age Group, 2017-2031
  • 12.3.1. Adults
  • 12.3.2. Pediatrics
• 12.4. Market Value Forecast By Application, 2017-2031
  • 12.4.1. Asthma
  • 12.4.2. COPD
  • 12.4.3. Others (Cystic Fibrosis, etc.)
• 12.5. Market Value Forecast By End-user, 2017-2031
  • 12.5.1. Hospitals
  • 12.5.2. Clinics
  • 12.5.3. Others (Home Care, etc.)
• 12.6. Market Value Forecast By Country, 2017-2031
  • 12.6.1. Germany
  • 12.6.2. U.K.
  • 12.6.3. France
  • 12.6.4. Italy
  • 12.6.5. Spain
  • 12.6.6. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Type
  • 12.7.2. By Age Group
  • 12.7.3. By Application
  • 12.7.4. By End-user
  • 12.7.5. By Country

13. Asia Pacific Soft Mist Inhalers Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Type, 2017-2031
  • 13.2.1. Disposable
  • 13.2.2. Reusable
• 13.3. Market Value Forecast By Age Group, 2017-2031
  • 13.3.1. Adults
  • 13.3.2. Pediatrics
• 13.4. Market Value Forecast By Application, 2017-2031
  • 13.4.1. Asthma
  • 13.4.2. COPD
  • 13.4.3. Others (Cystic Fibrosis, etc.)
• 13.5. Market Value Forecast By End-user, 2017-2031
  • 13.5.1. Hospitals
  • 13.5.2. Clinics
  • 13.5.3. Others (Home Care, etc.)
• 13.6. Market Value Forecast By Country, 2017-2031
  • 13.6.1. China
  • 13.6.2. India
  • 13.6.3. Japan
  • 13.6.4. Australia & New Zealand
  • 13.6.5. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Type
  • 13.7.2. By Age Group
  • 13.7.3. By Application
  • 13.7.4. By End-user
  • 13.7.5. By Country

14. Latin America Soft Mist Inhalers Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Type, 2017-2031
  • 14.2.1. Disposable
  • 14.2.2. Reusable
• 14.3. Market Value Forecast By Age Group, 2017-2031
  • 14.3.1. Adults
  • 14.3.2. Pediatrics
• 14.4. Market Value Forecast By Application, 2017-2031
  • 14.4.1. Asthma
  • 14.4.2. COPD
  • 14.4.3. Others (Cystic Fibrosis, etc.)
• 14.5. Market Value Forecast By End-user, 2017-2031
  • 14.5.1. Hospitals
  • 14.5.2. Clinics
  • 14.5.3. Others (Home Care, etc.)
• 14.6. Market Value Forecast By Country, 2017-2031
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Type
  • 14.7.2. By Age Group
  • 14.7.3. By Application
  • 14.7.4. By End-user
  • 14.7.5. By Country

15. Middle East & Africa Soft Mist Inhalers Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Type, 2017-2031
  • 15.2.1. Disposable
  • 15.2.2. Reusable
• 15.3. Market Value Forecast By Age Group, 2017-2031
  • 15.3.1. Adults
  • 15.3.2. Pediatrics
• 15.4. Market Value Forecast By Application, 2017-2031
  • 15.4.1. Asthma
  • 15.4.2. COPD
  • 15.4.3. Others (Cystic Fibrosis, etc.)
• 15.5. Market Value Forecast By End-user, 2017-2031
  • 15.5.1. Hospitals
  • 15.5.2. Clinics
  • 15.5.3. Others (Home Care, etc.)
• 15.6. Market Value Forecast By Country, 2017-2031
  • 15.6.1. GCC Countries
  • 15.6.2. South Africa
  • 15.6.3. Rest of Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Type
  • 15.7.2. By Age Group
  • 15.7.3. By Application
  • 15.7.4. By End-user
  • 15.7.5. By Country

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 16.2. Company Profiles
  • 16.2.1. Recipharm
  • 16.2.2. Boehringer Ingelheim
  • 16.2.3. Merxin Ltd
  • 16.2.4. DSB Medical Co., Ltd.
  • 16.2.5. Resyca BV
  • 16.2.6. Aero Pump GmbH
  • 16.2.7. Ursatec GmbH

17. Competition Landscape

• 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 17.2. Market Share Analysis By Company (2022)
• 17.3. Company Profiles
  • 17.3.1. Recipharm
    • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.1.2. Material Portfolio
    • 17.3.1.3. Financial Overview
    • 17.3.1.4. SWOT Analysis
    • 17.3.1.5. Strategic Overview
  • 17.3.2. Boehringer Ingelheim
    • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.2.2. Material Portfolio
    • 17.3.2.3. Financial Overview
    • 17.3.2.4. SWOT Analysis
    • 17.3.2.5. Strategic Overview
  • 17.3.3. Merxin Ltd.
    • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.3.2. Material Portfolio
    • 17.3.3.3. Financial Overview
    • 17.3.3.4. SWOT Analysis
    • 17.3.3.5. Strategic Overview
  • 17.3.4. DSB Medical Co., Ltd.
    • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.4.2. Material Portfolio
    • 17.3.4.3. Financial Overview
    • 17.3.4.4. SWOT Analysis
    • 17.3.4.5. Strategic Overview
  • 17.3.5. Resyca BV
    • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.5.2. Material Portfolio
    • 17.3.5.3. Financial Overview
    • 17.3.5.4. SWOT Analysis
    • 17.3.5.5. Strategic Overview
  • 17.3.6. Aero Pump GmbH
    • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.6.2. Material Portfolio
    • 17.3.6.3. Financial Overview
    • 17.3.6.4. SWOT Analysis
    • 17.3.6.5. Strategic Overview
  • 17.3.7. Ursatec GmbH
    • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 17.3.7.2. Material Portfolio
    • 17.3.7.3. Financial Overview
    • 17.3.7.4. SWOT Analysis
    • 17.3.7.5. Strategic Overview